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 Reversible Signal Regulation System of 19F NMR by Redox 
Reactions Using a Metal Complex as a Switching Module 
Kazuo Tanaka, Narufumi Kitamura, Yuichi Takahashi, and Yoshiki Chujo* 
Department of Polymer Chemistry, Graduate School of Engineering, Kyoto University, Katsura, Nishikyo-ku, Kyoto, 615-8510, Japan 
 
Abstract—We present here the reversible signal regulation of 19F NMR using the transition metal complex as a switching module. Water-
soluble fluorinated dendrimers containing ferrocene were synthesized as a probe, and the signal intensities of 19F NMR of the probes were 
monitored by changing the valence state of the ferrocene moiety. By oxidation of the ferrocene moiety, the relaxation of the nearby fluorine 
atoms was accelerated via the paramagnetic relaxation enhancement, as a result the 19F NMR signal from the probe was significantly 
decreased. The reduction of the ferrocenium cation of the probe recovered the signal intensity. Finally, in combination with the difference 
of the fluorescence quenching ability between ferrocene and ferrocenium cation, we constructed the multimodal 19F NMR / fluorescence 
probe based on the redox switching system. © 2010 Elsevier Science. All rights reserved 
̶ ̶ ̶  
* Corresponding author. Tel.: +81-75-383-2604; fax: +81-75-383-2605; e-mail: chujo@chujo.synchem.kyoto-u.ac.jp. 
1. Introduction 
Magnetic resonance imaging (MRI) is one of the powerful 
diagnostic tools in modern clinical medicine, and it can 
provide noninvasive, site-selective three-dimensional 
examination of biological events in living organisms with a 
contrast agents. 19F MRI using fluorinated compounds as 
the contrast agents has been paid attentions because less 
existence of endogenous fluorine atom gives the high signal 
to noise ratio in the images.1–6 In addition, much interest of 
recent researchers has directed to construct the system for 
monitoring the vital reactions using the stimuli-responsive 
molecules as MRI contrast agents, and several groups have 
reported the switching system of the 19F NMR signals for 
the detection of the enzymatic activity or the 
microenvironmental alteration.7–13 
The sensitivity of NMR signals was significantly 
influenced by paramagnetic relaxation enhancement (PRE) 
caused from the nearby paramagnetic metal ions such as 
Fe3+ or Gd3+ via the acceleration of the relaxation time.7 
The magnetism of ferrocene derivatives is dominated by 
the valence state of the Fe center.14–16 Neutral ferrocene 
derivatives display diamagnetism due to the closed shell 
electron structure. On the other hand, the ferrocenium 
cation can increase the relaxation rate of the solvent 
molecules via PRE caused from the unpaired electron.15 In 
particular, the switching of the valence state of ferrocene 
derivatives can reversibly proceed in aqueous media, and 
some of ferrocenium cation derivatives can exist stably in 
vivo.16 Thus, ferrocene derivatives are promised to be the 
reversible switch to regulate the signal intensity of NMR 
for monitoring redox-active species or environment under 
biological conditions. 
Herein, we describe the reversible regulation system for 19F 
NMR signals by the redox reactions. The water-soluble 
redox sensor for 19F NMR tethered ferrocene as the signal 
switching module was synthesized as a probe (Scheme 1), 
and the signal intensities of 19F NMR of the probes can be 
controlled via the modulation of the valence state of the 
ferrocene moiety. By oxidation of the ferrocene moiety, the 
relaxation of the nearby fluorine atoms was enhanced, as a 
result the 19F NMR signal from the probe was significantly 
decreased. The reduction of the ferrocenium cation of the 
probe recovered the signal intensity. Furthermore, in 
combination with the difference of the fluorescence 
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quenching ability between ferrocene and ferrocenium 
cation, we constructed the multimodal 19F NMR / 
fluorescence probe based on this redox switching system. 
To our knowledge, this is the first example using the metal 
complex as the reversible switch for 19F NMR signals. 
2. Results and Discussion 
2.1. Synthesis of the POSS-based probes 
The chemical structures of the ferrocene-tethered redox 
probe (Fc-POSS) are shown in Scheme 1. The probe is 
consisting of three parts, which are the ferrocene moiety for 
the signal modulation, trifluoroacetyl groups for the 19F 
NMR signal, and cubic octameric polyhedral oligomeric 
silsesquioxanes (POSS)17–20 as a water-soluble scaffold for 
the assembly of signal molecules.11–13 PRE strongly 
depends on a distance between paramagnetic species and 
observed nuclei, therefore compact structure of POSS (ca. 
1.5 nm diameter) compared to other water-soluble 
dendrimer such as a PAMAM dendrimer (2.9 nm diameter) 
has an advantage to be used as a scaffold for presenting 
PRE efficiently.7,21 The introduction of trifluoroacetyl 
groups and a ferrocence group into POSS was 
accomplished in good yield.22 The major product was 
identified with the modified POSS containing four 
ferrocene carboxylate groups from MALDI-TOF-MS 
spectra. The significant peak broadening following the 
decreasing of sensitivity of Fc-POSS was not observed by 
adding to BSA (1 mg/mL), the serum or the pH alteration 
between pH 5 to 9. These data suggest that undesired 
aggregation or non-specific adsorption of Fc-POSS could 
hardly exist in the measurements. In addition, the 
degradation of Fc-POSS was not observed after 24 h 
incubation at 37 °C at pH 7.0 in the presence of protease K. 
These results imply that ferrocene- and trifluoroacetyl-
containing POSS probes might be applicable for sensing 
with 19F MRI under biological conditions. 
2.2. Oxidation of the probes 
In order to evaluate the generation of the ferrocenium 
cation-containing POSS (Fc+-POSS) via the oxidation, we 
used ammonium persulfate (APS) as an oxidizer to the 
ferrocene moiety because less absorption of APS in the UV 
and visible region can provide quantitative data from 
b
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Scheme 2. Synthetic scheme of Fc-POSS and Flu-POSS. Reagents and 
Conditions: (a) i) ethyl trifluoroacetate, triethylamine, methanol, r.t., 3 h, 
ii) ferrocene carboxylic acid, DMT-MM, 72%, r.t., 3 h; (b) 5(6)-
fluorescein carboxylic acid, DMT-MM, methanol, 62%, r.t., 3 h. 
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Figure 1. UV absorption spectra of the sample containing 5 PM Fc-POSS 
with (magenta line) or without (blue line) 10 PM APS and 20 PM 
ferrocene carboxylic acid with (green line) or without (black line) 10 PM 
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Figure 2. Cyclic voltammogram of 1 mM Fc-POSS in the presence 
(magenta line) and absence (blue line) of 2 mM APS. 
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optical analysis. From UV spectra of Fc-POSS (5 PM) in 
50 mM sodium phosphate buffer (pH = 7.0), the addition of 
10 PM APS gave rise to the absorption band in the range of 
250–300 nm which corresponds to the LMCT absorbance 
band (1e1u → 2e1g) of the ferrocenium cation (Figure 1).14 
Cyclic voltammogram of Fc-POSS (1 mM) showed the 
disappearing of the first oxidation peak of the ferrocene 
moiety of Fc-POSS (+0.31 eV vs Ag/AgCl) in the presence 
of 2 mM APS (Figure 2). These results indicate that the 
oxidation of Fc-POSS should be effectively progressed by 
the addition of the equivalent of APS.  
2.3. Signal regulation with paramagnetic relaxation 
enhancement 
We evaluated the signal intensity of 19F NMR of the 
fluorinated POSS (1 mM) in 50 mM sodium phosphate 
buffer (pH = 7.0) at 25 °C (Figure 3a). In the case of 
fluorinated POSS without the ferrocene moiety, the signal 
intensity was not influenced even by the externally addition 
of ferrocenium cation (Samples 1 and 2). The significant 
decreasing of 19F NMR signal of Fc-POSS was observed by 
the addition of APS to the solution (Samples 3 and 4). The 
signal height obtained from the sample containing 2 mM 
APS decreased to 21% with broadening the half-width of 
the peak (''J = +31 Hz, Figure 3b). These results indicate 
that the ferrocence moiety covalently attached to POSS 
should be responsible for the signal regulation of 19F NMR, 
and strong dependency of PRE by the valence state of 
ferrocenium cation in the probe. 
We measured the longitudinal relaxation time (T1) and the 
transverse relaxation time (T2) of Fc-POSS in 19F NMR 
before and after oxidation. The T1 and T2 in the absence of 
APS were 0.673 and 0.660 s, respectively. In contrast, the 
values of relaxation times of Fc+-POSS were not 
determined, because of shorter relaxation times and the low 
signal intensity of the 19F resonance. From these results, it 
was confirmed that these acceleration of the relaxation 
times could be caused by PRE.7 These data indicate that the 
valence state of the ferrocene moiety should be crucially 
responsible for the signal intensity of 19F NMR, and the 
signal intensity can be controlled by redox reactions. Silver 
tetrafluoroborate and iron(III) chloride were applicable as 
an oxidizer of the ferrocene moiety in Fc-POSS, and we 
observed similar tendency of signal alteration to APS.16 
2.4. Reversible switching of 19F NMR signals 
In order to investigate the reversibility of the switching 
system of Fc-POSS, oxidation of Fc-POSS and its 
subsequent reduction were carried out over several cycles 
(Figure 4). Ascorbic acid which is a mild vital reductant 
was used for the reduction of Fc+-POSS. The 19F NMR 
signal intensity was recovered after each step and found to 
be rapidly and fully recovered on completion of the step; 
thus, demonstrating the reversibility of the switching 
process. As a result, a fast redox–19F NMR switch can be 
established on the basis of Fc-POSS by taking advantage of 
the properties of the ferrocene using as a magnetic switch. 
The reaction of Fc+-POSS with excess amounts of 
glutathione was carried out, however the reduction, 
followed by the signal recovering of 19F NMR was not 
observed. This result implies that this system could be 
applied to the selective sensing for various kinds of redox 
reactions in vivo by the modulation of the metal complexes 
in the probes. 
2.5. Stability of the probes in the buffer 
The decomposition of the complexes was followed by the 
decrease of the LMCT absorbance band during 250–300 
nm.16 For the examination of the stability of Fc+-POSS 
probe in water, the UV absorption monitoring of 5 PM Fc-
POSS at 250 and 270 nm in the presence of 100 PM APS at 
25 °C was executed (Figure 5). Slight reduction of UV 
absorption within 24 h incubation represents that less 
degradation of Fc+-POSS should occur. Theses data suggest 
that the decomposition of the ferrocene moiety can be 
ignored through the experiments. The stability of 
ferrocenium state in aqueous media largely depends on the 
counter anion.16 It can be expected to improve the stability 
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Figure 3. (a) 19F NMR signal intensities of fluorinated POSS (1 mM) in 
the presence and absence of 2 mM APS in 50 mM sodium phosphate 
buffer (pH = 7.0) at 25 °C. Sample 1, the fluorinated POSS without the 
ferrocene moiety in the absence of APS; sample 2, the fluorinated POSS 
without the ferrocene moiety in the presence of APS and external 
ferrocene carboxylic acid (4 mM); sample 3, Fc-POSS in the absence of 
APS; sample 4, Fc-POSS in the presence of APS. Each experiment was 
performed in triplicate and the error bars represent SD values. (b) 19F 
NMR spectra of Fc-POSS (1 mM) with (upper) or without (lower) 2 mM 
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Figure 4. Signal alteration of 19F NMR during stepwise oxidation and 
reduction cycles was carried out in 50 mM sodium phosphate buffer (pH 
= 7.0) with 1 mM Fc-POSS by the alternating addition of 2 mM APS (odd 
steps) and 4 mM ascorbic acid (even steps). Data points represent the 
average values obtained from three series of experiments, and the error 
bars represent SD values. 
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and elongate the life time of the probe by optimizing the 
counter anion under biological conditions. 
2.6. Bimodal detection with fluorescence and 19F NMR 
From the Stern-Volmer plots of fluorescein carboxylic acid 
with ferrocene carboxylic acid as a quencher, it was found 
that the oxidation state of ferrocene carboxylic acid has the 
higher quenching ability toward fluorescein carboxylic acid 
than that of the neutral form (Figure 6).23 Based on this 
phenomenon, we constructed the multimodal probe for 
fluorescence and a 19F NMR.24–32 We prepared the 
ferrocene- and fluorescein-tethered POSS (Flu-POSS), and 
fluorescence and 19F NMR signals of Flu-POSS were 
monitored in the presence or absence of APS. Figure 7 
represents the results and the multimodal detection of Flu-
POSS-containing solutions. Both fluorescence and 19F 
NMR signals were decreased by the addition of APS. In 
contrast, slight influence of the addition of APS was 
observed in fluorescence emission of fluorescein carboxylic 
acid. These results suggest that the ferrocene moiety can 
work as the switch for both of NMR and fluorescence 
signals simultaneously. Though the sensitivity of the probe 
for acquiring clear signals in the 19F NMR was lower than 
that for the fluorescence image, our system could have a 
possibility to improve sensitivity by employing POSS-core 
dendrimers for incorporating the larger number of fluorine 
atoms into the probe. 
3. Conclusion 
In conclusion, we present here the reversible signal 
regulation of 19F NMR using the ferrocene modified POSS. 
Their signal intensities of 19F NMR were dominated by the 
valence state of the ferrocene moiety of the probe via PRE. 
In addition, the ferrocene moiety can also regulate the 
intensity of fluorescence emission nearby the fluorophore, 
and finally the multimodal monitoring of oxidation with 19F 
NMR and fluorescence was realized. Although there is 
room to optimize the combination of the metal complexes 
and the oxidizers for reducing the toxicity and enhancing 
the stability under biological conditions, our system has a 
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Figure 7. (a) Fluorescence spectra of the sample containing 10 PM 
fluorescein carboxylic acid in the absence (blue line) or presence (light 
blue line) of 20 PM APS and 10 PM Flu-POSS in the absence (green line) 
or presence (magenta line) of 20 PM APS in 50 mM sodium phosphate 
buffer (pH = 7.0 at 25 °C with the excitation at 490 nm. (b) Multimodal 
detection of the sample containing Flu-POSS with fluorescence and 19F 
NMR spectroscopies. The fluorescence image of the same samples for the 
measurements of the fluorescence spectra was obtained using a 
transilluminator (365 nm). Signal intensity of 19F NMR obtained from the 
solution containing 1 mM Flu-POSS in 50 mM sodium phosphate buffer 
(pH = 7.0) with or without 2 mM APS at 25 °C. Each experiment was 
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Figure 6. Stern-Volmer plots of 10 PM 5(6)-fluorescein carboxylic acid 
in 50 mM sodium phosphate buffer (pH = 7.0) and 10% methanol in the 
presence (triangular dots) and absence (circular dots) of ferrocene 
carboxylic acid and APS at 25 °C. Square dots were obtained from the 
titration of APS only. The fluorescence emission was monitored with the 
excitation wavelength at 490 nm. The APS concentrations corresponded 
to that of 5(6)-fluorescein carboxylic acid. 















Figure 5. Stability of Fc+-POSS (5 PM) in the presence of 100 PM APS 
in 50 mM sodium phosphate buffer (pH = 7.0) at 25 °C. UV absorption 
was monitored at 250 nm (circular dots) and 270 nm (triangular dots). 
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active molecules but also other kinds of enzymes such as 
oxidases and reductases. In particular, for example, the 
detection for the differences of the redox environment 
between normal and cancer cells, such as the glutathione 
concentration or hypoxia can be expected to develop the 
early diagnosis methods of tumor. We can provide new 
strategy for molecular design of intelligent contrast agents 
for in vivo imaging. 
4. Experimental 
4.1. General 
1H NMR and 13C NMR spectra were measured with a 
JEOL EX-400 (400 MHz for 1H and 100 MHz for 13C) 
spectrometer. 19F NMR spectra were measured with a 
JEOL JNM-A400 (370 MHz) spectrometer. Coupling 
constants (J value) are reported in hertz. The chemical 
shifts are expressed in ppm downfield from 
tetramethylsilane, using residual chloroform (δ = 7.24 in 1H 
NMR, δ = 77.0 in 13C NMR) as an internal standard and 
trifluoroacetic acid in CDCl3 as an external standard. All 
samples were incubated for 30 min at 25 °C before 19F 
NMR measurements, and NMR spectra of these solutions 
were obtained within 90 sec after the accumulation of 8 
scans and 4 scans as a dummy. Masses of probes were 
determined with a MALDI-TOF mass spectroscopy 
(acceleration voltage 21 kV, negative mode) with DHB 
(2,5-dihydroxybenzoic acid) as a matrix. Transmission 
electron microscopy was performed using a JOEL JEM-
100SX operated at 100 kV. 
4.2. Preparation of Fc-POSS 
4.2.1. Octaammonium POSS (1).17–20 (3-
Aminopropyl)triethoxysilane (100 mL, 0.427 mol) and 35–
37% HCl (135 mL) in MeOH (800 mL) produced 1 as a 
white precipitate after 2 days at room temperature. The 
crude product obtained after filtration, washing with cold 
MeOH, and drying. The product was spectroscopically pure 
in 30% yield (18.8 g). Recrystallization from hot MeOH 
afforded 1 (4.29 g, 3.66 mmol, 6.88%) as a white solid. 1H 
NMR ((CD3)2SO, 25 °C): G 8.23 (s, 24H), 2.76 (t, 16H), 
1.71 (m, 16H), 0.72 (t, 16H). 13C NMR ((CD3)2SO, 25 °C): G 40.53, 20.13, and 7.96. 29SiNMR((CD3)2SO, 25 °C): G –
66.4 (s). 
4.2.2. Fc-POSS (2). To a suspension of POSS 1 (1 g, 0.852 
mmol) and ethyl trifluoroacetate (55 PL, 0.837 mmol) in 
methanol (20 mL), triethylamine (2 mL, 14.4 mmol) was 
added, and the reaction mixture was stirred at room 
temperature. After stirring for 3h, ferrocene carboxylic acid 
(196 mg, 3.44 mmol) and DMT-MM (1.92 g, 5.16 mmol) 
were added to the mixture. After stirring for additional 3 h, 
the resulting mixture was directly dialyzed in distilled 
water, and the following evaporation gave the brown solid 
Fc-POSS (2) 1.11 g (0.613 mmol, 72%) The resulting 
product contained statistical byproducts which have, on 
average, four ferrocene groups according to 1H NMR 
spectrum. From the peak height in the MALDI–TOF MS 
spectra, the existing ratio was evaluated as 3 : 4 : 3 (the 
number of the ferrocence goups as 3, 4, and 5, respectively). 
1H NMR (DMSO, 400 MHz) G 9.50 (br, 5H), 7.95 (br, 6H), 
4.67 (br, 2H), 4.41 (br, 2H), 4.19 (s, 5H), 3.14 (br, 6H), 
2.76 (br, 10H), 1.69 (br, 6H), 1.55 (br, 10H), 0.68 (br, 6H), 
0.60 (br, 10H): 13C NMR (DMSO, 100 MHz) G 173.2, 
155.9, 117.4, 70.46, 69.93, 69.35, 68.34, 41.52, 40.92, 
21.76, 20.05, 8.77, 8.72: 19F NMR (D2O, 373 MHz) G –
75.4: MALDI–TOF [(M(Fc=3)+H)+] calcd. 1614.59, found 
1614.39, [(M(Fc=4)+H)+] calcd. 1826.62, found 1826.97, 
[(M(Fc=5)+H)+] calcd. 2038.64, found 2038.23. 
4.2.3. Flu-POSS (3). To a suspension of Fc-POSS, (500 
mg, 0.276 mmol), triethylamine (2 mL, 14.4 mmol), and 
DMT-MM (129 mg, 0.372 mmol) in methanol (20 mL), 
fluorescein-5(6)-carboxylic acid (118 mg, 0.304 mmol) was 
added, and the reaction mixture was stirred at room 
temperature. After stirring for 3h, the resulting mixture was 
directly dialyzed in distilled water, and the following 
evaporation gave the brown solid Flu-POSS (3) (371 mg, 
0.171 mmol, 62%) The resulting product contained 
statistical byproducts which have, on average, four 
ferrocene groups according to 1H NMR spectrum. 1H NMR 
(DMSO, 400 MHz) G 9.50 (br, 6H), 9.41 (br, 2H), 8.32 (br, 
0.5H), 8.22 (br, 0.5H), 8.10 (br, 0.5H), 7.99 (br, 0.5H), 7.85 
(br, 4H), 7.51 (br, 0.5H), 7.29 (br, 0.5H), 6.70 (br, 2H), 
6.51 (br, 4H), 4.61 (br, 2H), 4.32 (br, 2H), 4.13 (s, 5H), 
3.11 (br, 4H), 2.73 (br, 12H), 1.64 (br, 4H), 1.51 (br, 12H), 
0.68 (br, 4H), 0.57 (br, 12H): 13C NMR (DMSO, 100 MHz) 
G 173.2, 168.6, 168.5, 167.6, 166.7, 160.2, 156.2, 152.0, 
136.6, 133.4, 131.6, 131.5, 130.1, 129.0, 127.4, 127.1, 
126.4, 124.9, 124.0, 123.4, 113.0, 117.5, 111.7, 109.6, 
102.4, 87.5, 87.0, 70.27, 69.88, 69.26, 68.28, 41.45, 40.12, 
21.76, 20.73, 9.16, 8.50: 19F NMR (D2O, 373 MHz) G –
75.2: MALDI–TOF [(M(Fc=3)+H)+] calcd. 1972.89, found 
1972.40, [(M(Fc=4)+H)+] calcd. 2184.92, found 2184.88, 
[(M(Fc=5)+H)+] calcd. 2396.94, found 2396.18. 
4.3. CV measurements 
The current was measured in a three-electrode arrangement 
(ALS, model CV–50W), a glassy carbon working electrode 
(electrode area, 3 mm2), a platinum counter electrode, and 
an Ag/AgCl reference electrode at 25 °C. The current 
measurements were performed with the Fc-POSS solution 
(1 mM) in the presence and absence of APS (2 mM) in 50 
mM sodium phosphate (pH = 7.0). CV conditions were 100 
mV / min sweep speed, initial potential 0 V, and end 
potential +1.0 V. 
4.4. Evaluation of the stability of Fc-POSS in water 
from the UV–vis spectrum 
The UV–vis spectrum of Fc-POSS (5 PM) was taken in 50 
mM sodium phosphate buffers (pH = 7.0). Absorbance vs 
time profiles were measured at 250 nm using a Shimadzu 
UV-3600 spectrophotometer using 1 cm path length cell at 
25 °C. 
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4.5. Stepwise oxidation and reduction experiments 
monitored by 19F NMR 
The samples (0.5 mL) containing 1 mM Fc-POSS in 50 
mM sodium phosphate buffer (pH = 7.0) were alternatively 
added to 2 PL of 1 M APS and 4 PL of 1 M ascorbic acid 
and then measured with 19F NMR at 25 °C. 
4.6. Fluorescence measurements of Flu-POSS 
The fluorescence emission of Flu-POSS solution (10 PM) 
in the presence and absence of APS (20 PM) under 
excitation at 490 nm was monitored using a Perkin Elmer 
LS50B at 25 °C using 1 cm path length cell. The excitation 
bandwidth was 1 nm. The emission bandwidth was 1 nm. 
The picture was obtained with the irradiation using the 
transilluminator (365 nm). 
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